Clinical Trials Directory

Trials / Conditions / Lassa Virus Infection

Lassa Virus Infection

7 registered clinical trials studyying Lassa Virus Infection.

StatusTrialSponsorPhase
CompletedA Comparison of the Pharmacokinetic Properties of ARN-75039 Tablets With Excipients to Neat ARN-75039 in Hydro
NCT06911242
Arisan Therapeutics, Inc.Phase 1
CompletedA Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral ARN-75039 in Healthy Adult Subjects
NCT05735249
Arisan Therapeutics, Inc.Phase 1
UnknownA Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-LASV-GPC Vaccine in Adults in Good Genera
NCT04794218
International AIDS Vaccine InitiativePhase 1
CompletedPrevalence and Incidence of Lassa Virus Infection in Southern Mali
NCT03783143
National Institute of Allergy and Infectious Diseases (NIAID)—
CompletedA Trial to Evaluate the Optimal Dose of MV-LASV (V182-001)
NCT04055454
Themis Bioscience GmbHPhase 1
Active Not RecruitingLassa Fever Clinical Course and Prognostic Factors in Nigeria
NCT03655561
Alliance for International Medical Action—
CompletedSeroprevalence and Incidence of Lassa Fever in the Rural Commune of Sibirila, District of Bougouni, Mali
NCT02311387
National Institute of Allergy and Infectious Diseases (NIAID)—